ADAM17 deletion in thymic epithelial cells alters aire expression without affecting T cell developmental progression

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Gravano, David M ^a   McLelland, Bryce T ^a   Horiuchi, Keisuke ^b   Manilay, Jennifer O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; CRE RECOMBINASE; METALLOPROTEINASE; PROTEIN ADAM17; UNCLASSIFIED DRUG; ADAM PROTEIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EPITHELIUM CELL; GENE DELETION; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; T LYMPHOCYTE; THYMUS; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

MUS;

ADAM PROTEINS; ANIMALS; EPITHELIAL CELLS; MICE; MICE, KNOCKOUT; T-LYMPHOCYTES; THYMUS GLAND;

EID: 78149457953     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013528     Document Type: Article

References (59)

1. Petrie HT, Zuniga-Pflucker JC (2007) Zoned out: functional mapping of stromal signaling microenvironments in the thymus. Annu Rev Immunol 25: 649-679.
2. Godfrey DI, Kennedy J, Suda T, Zlotnik A (1993) A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4- CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol 150: 4244-4252.
3. Hollander G, Gill J, Zuklys S, Iwanami N, Liu C, et al. (2006) Cellular and molecular events during early thymus development. Immunol Rev 209: 28-46.
4. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385: 729-733.
5. Blobel CP (2005) ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6: 32-43.
6. Edwards DR, Handsley MM, Pennington CJ (2008) The ADAM metalloproteinases. Mol Aspects Med 29: 258-289.
7. Kheradmand F, Werb Z (2002) Shedding light on sheddases: role in growth and development. Bioessays 24: 8-12.
8. Brown MS, Ye J, Rawson RB, Goldstein JL (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100: 391-398.
9. Murphy G, Murthy A, Khokha R (2008) Clipping, shedding and RIPping keep immunity on cue. Trends Immunol 29: 75-82.
10. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factoralpha. Nature 385: 733-736.
11. Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, et al. (2000) Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275: 14608-14614.
12. Solomon KA, Pesti N, Wu G, Newton RC (1999) Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion. J Immunol 163: 4105-4108.
13. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, et al. (2000) A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell 5: 207-216.
14. Dyczynska E, Sun D, Yi H, Sehara-Fujisawa A, Blobel CP, et al. (2007) Proteolytic processing of delta-like 1 by ADAM proteases. J Biol Chem 282: 436-444.
15. Kawaguchi N, Horiuchi K, Becherer JD, Toyama Y, Besmer P, et al. (2007) Different ADAMs have distinct influences on Kit ligand processing: phorbolester- stimulated ectodomain shedding of Kitl1 by ADAM17 is reduced by ADAM19. J Cell Sci 120: 943-952.
16. Contin C, Pitard V, Itai T, Nagata S, Moreau JF, et al. (2003) Membraneanchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling. J Biol Chem 278: 32801-32809.
17. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, et al. (1998) An essential role for ectodomain shedding in mammalian development. Science 282: 1281-1284.
18. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, et al. (2001) Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276: 37993-38001.
19. Li N, Wang Y, Forbes K, Vignali KM, Heale BS, et al. (2007) Metalloproteases regulate T-cell proliferation and effector function via LAG-3. EMBO J 26: 494-504.
20. Horiuchi K, Morioka H, Takaishi H, Akiyama H, Blobel CP, et al. (2009) Ectodomain shedding of FLT3 ligand is mediated by TNF-alpha converting enzyme. J Immunol 182: 7408-7414.
21. Shi W, Chen H, Sun J, Buckley S, Zhao J, et al. (2003) TACE is required for fetal murine cardiac development and modeling. Dev Biol 261: 371-380.
22. Sternlicht MD, Sunnarborg SW, Kouros-Mehr H, Yu Y, Lee DC, et al. (2005) Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132: 3923-3933.
23. Horiuchi K, Kimura T, Miyamoto T, Takaishi H, Okada Y, et al. (2007) Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J Immunol 179: 2686-2689.
24. Gelling RW, Yan W, Al-Noori S, Pardini A, Morton GJ, et al. (2008) Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice. Endocrinology 149: 6053-6064.
25. Li N, Boyd K, Dempsey PJ, Vignali DA (2007) Non-Cell Autonomous Expression of TNF-{alpha}-Converting Enzyme ADAM17 Is Required for Normal Lymphocyte Development. J Immunol 178: 4214-4221.
26. Gravano DM, Manilay JO (2010) Inhibition of proteolysis of Delta-like-1 does not promote or reduce T-cell developmental potential. Immunol Cell Biol.
27. Gordon J, Xiao S, Hughes B, 3rd, Su DM, Navarre SP, et al. (2007) Specific expression of lacZ and cre recombinase in fetal thymic epithelial cells by multiplex gene targeting at the Foxn1 locus. BMC Dev Biol 7: 69.
28. Koch U, Fiorini E, Benedito R, Besseyrias V, Schuster-Gossler K, et al. (2008) Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. J Exp Med 205: 2515-2523.
29. Mathis D, Benoist C (2009) Aire. Annu Rev Immunol 27: 287-312.
30. Derbinski J, Gabler J, Brors B, Tierling S, Jonnakuty S, et al. (2005) Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med 202: 33-45.
31. Klug DB, Carter C, Crouch E, Roop D, Conti CJ, et al. (1998) Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc Natl Acad Sci U S A 95: 11822-11827.
32. Nishikawa Y, Hirota F, Yano M, Kitajima H, Miyazaki J, et al. (2010) Biphasic Aire expression in early embryos and in medullary thymic epithelial cells before end-stage terminal differentiation. J Exp Med 207: 963-971.
33. Gray D, Abramson J, Benoist C, Mathis D (2007) Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J Exp Med 204: 2521-2528.
34. Seach N, Ueno T, Fletcher AL, Lowen T, Mattesich M, et al. (2008) The lymphotoxin pathway regulates Aire-independent expression of ectopic genes and chemokines in thymic stromal cells. J Immunol 180: 5384-5392.
35. Gray DH, Tull D, Ueno T, Seach N, Classon BJ, et al. (2007) A unique thymic fibroblast population revealed by the monoclonal antibody MTS-15. J Immunol 178: 4956-4965.
36. Anderson G, Jenkinson WE, Jones T, Parnell SM, Kinsella FA, et al. (2006) Establishment and functioning of intrathymic microenvironments. Immunol Rev 209: 10-27.
37. Shinohara T, Honjo T (1996) Epidermal growth factor can replace thymic mesenchyme in induction of embryonic thymus morphogenesis in vitro. Eur J Immunol 26: 747-752.
38. Anderson G, Anderson KL, Tchilian EZ, Owen JJ, Jenkinson EJ (1997) Fibroblast dependency during early thymocyte development maps to the CD25+ CD44+ stage and involves interactions with fibroblast matrix molecules. Eur J Immunol 27: 1200-1206.
39. Suniara RK, Jenkinson EJ, Owen JJ (2000) An essential role for thymic mesenchyme in early T cell development. J Exp Med 191: 1051-1056.
40. Foster K, Sheridan J, Veiga-Fernandes H, Roderick K, Pachnis V, et al. (2008) Contribution of neural crest-derived cells in the embryonic and adult thymus. J Immunol 180: 3183-3189.
41. Zachariah MA, Cyster JG (2010) Neural crest-derived pericytes promote egress of mature thymocytes at the corticomedullary junction. Science 328: 1129-1135.
42. Ashwell JD, Lu FW, Vacchio MS (2000) Glucocorticoids in T cell development and function*. Annu Rev Immunol 18: 309-345.
43. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, et al. (1999) Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 104: 1051-1059.
44. Trotter-Mayo RN, Roberts MR (2008) Leptin acts in the periphery to protect thymocytes from glucocorticoid-mediated apoptosis in the absence of weight loss. Endocrinology 149: 5209-5218.
45. Ramsey C, Winqvist O, Puhakka L, Halonen M, Moro A, et al. (2002) Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 11: 397-409.
46. Jiang W, Anderson MS, Bronson R, Mathis D, Benoist C (2005) Modifier loci condition autoimmunity provoked by Aire deficiency. J Exp Med 202: 805-815.
47. Kuroda N, Mitani T, Takeda N, Ishimaru N, Arakaki R, et al. (2005) Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J Immunol 174: 1862-1870.
48. Chin RK, Lo JC, Kim O, Blink SE, Christiansen PA, et al. (2003) Lymphotoxin pathway directs thymic Aire expression. Nat Immunol 4: 1121-1127.
49. Boehm T, Scheu S, Pfeffer K, Bleul CC (2003) Thymic medullary epithelial cell differentiation, thymocyte emigration, and the control of autoimmunity require lympho-epithelial cross talk via LTbetaR. J Exp Med 198: 757-769.
50. Ruan QG, Wang CY, Shi JD, She JX (1999) Expression and alternative splicing of the mouse autoimmune regulator gene (Aire). J Autoimmun 13: 307-313.
51. Hakozaki A, Yoda M, Tohmonda T, Furukawa M, Hikata T, et al. (2010) Receptor activator of NF-kappaB (RANK) ligand induces ectodomain shedding of RANK in murine RAW264.7 macrophages. J Immunol 184: 2442-2448.
52. Akiyama T, Shimo Y, Yanai H, Qin J, Ohshima D, et al. (2008) The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 29: 423-437.
53. Hikosaka Y, Nitta T, Ohigashi I, Yano K, Ishimaru N, et al. (2008) The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. Immunity 29: 438-450.
54. Rossi SW, Kim MY, Leibbrandt A, Parnell SM, Jenkinson WE, et al. (2007) RANK signals from CD4(+)3(-) inducer cells regulate development of Aireexpressing epithelial cells in the thymic medulla. J Exp Med 204: 1267-1272.
55. Horiuchi K, Kimura T, Miyamoto T, Miyamoto K, Akiyama H, et al. (2009) Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF. J Immunol 182: 2093-2101.
56. Weskamp G, Mendelson K, Swendeman S, Le Gall S, Ma Y, et al. (2010) Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ Res 106: 932-940.
57. Gray DH, Seach N, Ueno T, Milton MK, Liston A, et al. (2006) Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood 108: 3777-3785.
58. Varnum-Finney B, Dallas MH, Kato K, Bernstein ID (2008) Notch target Hes5 ensures appropriate Notch induced T- versus B-cell choices in the thymus. Blood 111: 2615-2620.
59. Dooley J, Erickson M, Farr AG (2008) Alterations of the medullary epithelial compartment in the Aire-deficient thymus: implications for programs of thymic epithelial differentiation. J Immunol 181: 5225-5232.